Varaico: Literature-Extracted Genetic Variants

Gene:SUCLA2
Variant:p.D333G
Back to variants list

SUCLA2

NM_003850.3:p.D333G

Associated Papers

Clinical and genetic characterisation of childhood-onset sensorineural hearing loss reveal associated phenotypes and enrichment of pathogenic founder mutations in the Finnish population.

Kraatari-Tiri M et al.

International Journal of Audiology, 2025

Impact of missense mutations on the structure-function relationship of human succinyl-CoA synthetase using in silico analysis.

Elabed S et al.

Mitochondrion, 2025

Genetic landscape of primary mitochondrial diseases in children and adults using molecular genetics and genomic investigations of mitochondrial and nuclear genome.

Ambrose A et al.

Orphanet Journal of Rare Diseases, 2024

39533303 (PubMed )
Supplement: 13023_2024_3437_MOESM9_ESM.xlsx › Nuclear

Succinyl-CoA Synthetase Dysfunction as a Mechanism of Mitochondrial Encephalomyopathy: More than Just an Oxidative Energy Deficit.

Lancaster MS et al.

International Journal of Molecular Sciences, 2023

SUCLA2 Arg407Trp mutation can cause a nonprogressive movement disorder - deafness syndrome.

Alkhater RA et al.

Annals of Clinical and Translational Neurology, 2021

SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease.

Gut P et al.

Nature Communications, 2020

Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome.

Couser NL et al.

American Journal of Medical Genetics. Part A, 2017

Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.

Carrozzo R et al.

Journal of Inherited Metabolic Disease, 2016

SUCLA2 Deficiency: A Deafness-Dystonia Syndrome with Distinctive Metabolic Findings (Report of a New Patient and Review of the Literature).

Maas RR et al.

Jimd Reports, 2016

Rapid Detection of Rare Deleterious Variants by Next Generation Sequencing with Optional Microarray SNP Genotype Data.

Watson CM et al.

Human Mutation, 2015

Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.

Matilainen S et al.

European Journal of Human Genetics : Ejhg, 2015

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."